11 Apr. 2019
ECO - DAS WIRTSCHAFTSMAGAZIN
ECO - Das Wirtschaftsmagazin; Neue Antibiotika Neue Antibiotika: Wenig Anreize für Big Pharma; BioVersys bei 3:52 Minuten
11 Apr. 2019
WORLD ECONOMIC FORUM IN DAVOS
World Economic Forum in Davos: Figures suggest drug-resistant infections could kill an extra 10 million people across the world every year by 2050...
11 Apr. 2019
BRAND EINS
Brand Eins: Die Resistente Industrie Das Antibiotika-Fakten-Dossier ist zu finden auf Antibiotika: Die resistente Industrie antibiotika.brandeins.d...
11 Apr. 2019
EU HEALTH CHIEF
EU Health Chief: Superbugs one of greatest threats to mankind Read Article here
Recent Media Feeds
- Press Release - BioVersys hires new CDO, Dr. Glenn Dale
- Eurostars Funds IMPACT2 Press Release
- Dr. Gitzinger will be speaking at the UNCTAD/WHO event in Geneva, October 23rd, 2018 from 14:30-17:30 on Fostering investment in the development of new antibacterial treatments
- CARB-X welcomes UK Government and Bill & Melinda Gates Foundation as new partners
- BioVersys successfully closes Series A2 financing round
- October 20th, 2017; BioVersys and Marc Gitzinger were featured in the 3Sat news.
- BEAM Alliance fordert G20 Staaten zu mehr Unterstützung im Kampf gegen tödliche Superkeime auf
- Swiss biopharma BioVersys is collaborating with drug discovery and development CRO Aptuit on the discovery and development of new targets and drug candidates against Gram-negative bacteria, including drug-resistant strains. An existing BioVersys target will be included in the partnership.
- Press Release BEAM Alliance / Biocom AG
- Breaking through the Wall ... A Call for Concerted Action on AB Research and Development
